Delta Asset Management LLC TN Has $141,000 Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Delta Asset Management LLC TN reduced its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 7.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,802 shares of the company’s stock after selling 147 shares during the quarter. Delta Asset Management LLC TN’s holdings in GE HealthCare Technologies were worth $141,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of GEHC. Thrivent Financial for Lutherans raised its stake in shares of GE HealthCare Technologies by 16.5% in the third quarter. Thrivent Financial for Lutherans now owns 25,408 shares of the company’s stock valued at $2,385,000 after purchasing an additional 3,602 shares in the last quarter. Cerity Partners LLC raised its stake in shares of GE HealthCare Technologies by 24.2% in the 3rd quarter. Cerity Partners LLC now owns 67,896 shares of the company’s stock valued at $6,372,000 after buying an additional 13,228 shares in the last quarter. Kingsview Wealth Management LLC boosted its position in shares of GE HealthCare Technologies by 5.4% during the 3rd quarter. Kingsview Wealth Management LLC now owns 10,624 shares of the company’s stock valued at $997,000 after acquiring an additional 545 shares in the last quarter. Swedbank AB increased its stake in GE HealthCare Technologies by 6.6% in the third quarter. Swedbank AB now owns 72,013 shares of the company’s stock valued at $6,758,000 after acquiring an additional 4,490 shares during the period. Finally, Larson Financial Group LLC raised its position in GE HealthCare Technologies by 223.3% in the third quarter. Larson Financial Group LLC now owns 3,142 shares of the company’s stock worth $295,000 after purchasing an additional 2,170 shares in the last quarter. 82.06% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on GEHC. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their price objective for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. The Goldman Sachs Group upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $85.00 to $100.00 in a research note on Tuesday, March 11th. Citigroup boosted their target price on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research note on Thursday, February 13th. Finally, Wells Fargo & Company increased their target price on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, GE HealthCare Technologies currently has a consensus rating of “Moderate Buy” and an average price target of $98.75.

GE HealthCare Technologies Stock Performance

GEHC stock opened at $81.00 on Thursday. The company has a 50 day moving average price of $86.86 and a 200 day moving average price of $85.93. GE HealthCare Technologies Inc. has a fifty-two week low of $74.51 and a fifty-two week high of $94.80. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. The stock has a market capitalization of $37.04 billion, a PE ratio of 18.71, a price-to-earnings-growth ratio of 3.19 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.19. The business had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. Analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.